Ken Ohyama

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA

Ryoji Nishi, Haruki Koike, Ken Ohyama et al. · Neurology · 2020 · 80 citations

Clinicopathologic features of folate-deficiency neuropathy

Haruki Koike, Mie Takahashi, Ken Ohyama et al. · Neurology · 2015 · 71 citations

Correlation Between Skeletal Muscle Mass Deficit and Poor Functional Outcome in Patients with Acute Ischemic Stroke

Ken Ohyama, M. Watanabe, Yasunobu Nosaki et al. · Journal of Stroke and Cerebrovascular Diseases · 2020 · 55 citations

Poor Functional Outcome, Stroke Rehabilitation, Ischemic Stroke +15

IgG4-Related Neuropathy

Ken Ohyama, Haruki Koike, Masahiro Iijima et al. · JAMA Neurology · 2013 · 42 citations